MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions
View by Date
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • The highly-selective metabotropic glutamate receptor 2 positive allosteric modulator LY-487,379 alleviates psychosis-like behaviours and dyskinesia in the MPTP-lesioned marmoset

    L. Sid-Otmane, S. Nuara, A. Hamadjida, N. Veyres, C. Rouillard, M. Panisset, J. Gourdon, P. Huot (Montreal, QC, Canada)

  • The highly-selective mGluR2 positive allosteric modulator LY-487,379 alleviates L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson’s disease

    C. Kwan, I. Frouni, V. Nafade, D. Gagnon, M.-J. Wallman, L. Sid-Otmane, M. Parent, A. Parent, C. Rouillard, H. Adjia, P. Huot (Montreal, QC, Canada)

  • The Huntington’s Disease Health Index Study (HD-HI)

    A. Glidden, E. Luebbe, M. Elson, S. Goldenthal, R. Dorsey, C. Heatwole (Rochester, NY, USA)

  • The identification of molecular-genetic background of familial atypical parkinsonism in “Hornacko”, a specific region of the south-eastern Moravia, Czech Republic.

    K. Mensikova, R. Vodicka, K. Kolarikova, T. Bartonikova, P. Kanovsky (Olomouc, Czech Republic)

  • The Impact of Cognitive Changes on Everyday Life for People with Parkinson’s: The Patient’s Perspective

    J. Wertheimer, A. Gottuso, A. Duboille, M. Tuchman, C. Walton (Los Angeles, CA, USA)

  • The impact of divided attention in dual task conditions on drooling in Parkinson’s Disease (PD): a pilot study

    H. Reynolds, N. Miller, R. Walker (Gateshead, United Kingdom)

  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease

    M. Nagai, M. Kubo, H. Iwaki, R. Ando, M. Nomoto (Ehime, Japan)

  • The impact of intensive voice treatment on swallowing in Parkinson disease

    D. McFarland, L. Ramig, B. Martin-Harris, K. Humphries, J. Logemann, K. Freeman, A. Halpern, J. Spielman (Montréal, QC, Canada)

  • The impact of Parkinson’s disease on faith and spirituality

    A. Weldehana (Addis Ababa, Ethiopia)

  • The Importance of Ultrasonographic Evaluation in the Diagnosis of Dysphagia in Parkinson Disease

    E. Umay, E. Ozturk, I. Gundogdu, O. Delibas, B. Gonenli, A. Cakci (Ankara, Turkey)

  • « Previous Page
  • 1
  • …
  • 137
  • 138
  • 139
  • 140
  • 141
  • …
  • 155
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley